European Journal of Dermatology
MENUPityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonists Volume 23, numéro 6, November-December 2013
Illustrations
Department of Dermatology,
Rudolfstiftung Hospital,
Juchgasse 25,
1030 Vienna, Austria, Department of Dermatology,
Mount Zion Cancer Research Center,
San Francisco, CA 94115, USA
- DOI : 10.1684/ejd.2013.2175
- Page(s) : 895-6
- Année de parution : 2013
ejd.2013.2175 Auteur(s) : Igor Vujic1,2 igor.vujic@wienkav.at, Leo Richter1, Katrin Bartsch1, Babak Monshi1, Klemens Rappersberger1 1 Department of Dermatology, Rudolfstiftung Hospital, Juchgasse 25, 1030 Vienna, Austria 2 Department of Dermatology, Mount Zion Cancer Research Center, San Francisco, CA 94115, USA Pityriasis rubra pilaris (PRP) is a rare, inflammatory, papulosquamous disease of unknown etiology. It is classified into 6 different types [1-3]. Type 1 PRP accounts for 50% of cases, the onset [...]